Article
Genetic variants in trinucleotide repeat-containing 9 (TNRC9) are associated with risk of estrogen receptor positive breast cancer in a Chinese population.
Breast cancer research and treatment - 1 Nov 2010
Liang Jie, Chen Peizhan, Hu Zhibin, Shen Hao, Wang Furu, Chen Lu, Li Mian, Tang Jinhai, Wang Hui, Shen Hongbing
Abstract excerpt
Trinucleotide repeat-containing 9 (TNRC9), a high mobility group chromatin-associated protein, has been implicated in breast cancer metastasis to the bone. Recently, several single nucleotide polymorphisms (SNPs) of TNRC9 were identified as novel breast cancer susceptibility loci by whole genome association studies, especially in estrogen receptor (ER) positive tumors. In the present case-control study of 1,049...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.